<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Patients with stages I and II of vascular <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> developing on the background of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> were treated with ascovertin during 21 days </plain></SENT>
<SENT sid="1" pm="."><plain>Ascovertin is a complex of <z:chebi fb="5" ids="47916">flavonoid</z:chebi> dihydroquercetin and <z:chebi fb="6" ids="22652,29073">ascorbic acid</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>The study group included 21 patients aged 45-65 years and a comparison group consisted of 10 age-matched patients un treated with ascovertin </plain></SENT>
<SENT sid="3" pm="."><plain>The ascovertin treatment relieved <z:hpo ids='HP_0002315'>headache</z:hpo>, reduced <z:hpo ids='HP_0002321'>vertigo</z:hpo> and <z:mp ids='MP_0002899'>fatigability</z:mp>, improved cognitive functions </plain></SENT>
<SENT sid="4" pm="."><plain>The reliable diminishing of whole blood viscosity due to improvement of cellular rheology indices (decrease of aggregation and increase of erythrocyte deformability as well as decrease of indices of <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation in erythrocyte membrane and blood plasma) was observed in the stydy group but not in the comparison one </plain></SENT>
</text></document>